Hematology/Oncology

Top Story

Arti Hurria, MD, found her ‘perfect fit’ in geriatric oncology

Arti Hurria, MD, found her ‘perfect fit’ in geriatric oncology
May 27, 2016

Arti Hurria, MD, is professor of medical oncology, co-lead of the cancer control and population sciences, and director of the cancer and aging research program at City of Hope Comprehensive Cancer Center.

In the Journals

Benefit of increased resection extent varies by molecular subgroup in medulloblastoma

May 27, 2016
The degree to which extent of resection served as a prognostic marker for patients with medulloblastoma may heavily depend on molecular subgroup affiliation, according…
In the Journals

Limited treatment safe, successful for pediatric patients with lymphocyte-predominant Hodgkin lymphoma

May 27, 2016
A majority of highly selected pediatric patients with lymphocyte-predominant Hodgkin lymphoma may be successfully treated with surgery alone, according to study results…
In the Journals

Surgeon’s proficiency in esophagectomy affects short- and long-term cancer outcomes

May 26, 2016
Undergoing esophagectomy with a surgeon who had performed at least 15 surgeries reduced short-term mortality among patients with esophageal cancer, according to results…
Meeting News Coverage

Top Takeaways from ASH: Benefits, drawbacks of Factor VIII products require discussion with patients

May 26, 2016
The multicenter, randomized Survey of Inhibitors in Plasma-Product Exposed Toddlers, or SIPPET study, presented at the ASH Annual Meeting and Exposition, which…
More News Headlines »
CME Video

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Video

VIDEO: Understanding of genetics in AML, MDS help predict prognosis, response to treatment

May 6, 2016
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan